Atherosclerosis vaccine
Good news for patients who are not helped by existing cholesterol-lowering methods: injections of antibodies binding to "bad" cholesterol molecules showed good results in a trial on healthy volunteers.
16.11.2011Good news for patients who are not helped by existing cholesterol-lowering methods: injections of antibodies binding to "bad" cholesterol molecules showed good results in a trial on healthy volunteers.
16.11.2011The developer of a drug that stimulates the growth of eyelashes will test the effectiveness of the drug for baldness.
16.11.2011An experimental drug that selectively destroys blood vessels that feed fat cells allowed obese macaques to lose up to 11% of their weight and up to 27% of fat reserves in the abdominal area in 4 weeks.
15.11.2011The drug Stelara (ustekinumab), which is 100% monoclonal human antibodies, opens a new class of drugs for the treatment of psoriasis.
10.11.2011Two existing tests detect human papillomavirus with a sufficiently high sensitivity – 84 and 91%. In addition, all the women who tried the test for self-conducting called this method simple and easy.
25.10.2011Testosterone levels do not affect life expectancy. Moreover, we do not know anything about whether it does not lead to premature death itself if you start taking it in the hope of improving the heart.
24.10.2011The new technique "trains" the recipient's immune system to accept donor cells for its own and allows you to do without taking immunosuppressants after organ transplantation.
07.10.2011According to the authors of the article, monoclonal antibody therapy, despite its commercial attractiveness, is not a promising direction for long-term treatment.
05.10.2011Sanofi Pasteur has signed a contract with the University of California, San Diego to develop a vaccine for the prevention and treatment of acne, also known as acne or acne rash.
28.09.2011A few weeks after a single injection of the JX-594 virus culture to patients with metastatic cancer, half of the participants in the experiment had the tumor stopped growing, and one even decreased in size.
02.09.2011The primary results of a clinical study of the drug guanfacine, originally intended for the treatment of hypertension, showed that no reduces the symptoms of senile disorders of short-term memory.
29.07.2011In response to the introduction of the "dynamic vaccine", antibodies against heroin and its derivatives began to be synthesized in the body. As a result, four out of seven experimental drug addicts voluntarily and without additional treatment refused heroin.
22.07.2011After treatment of mice with an Alzheimer's disease model with polyphenols isolated from grape seeds, the content of the beta-amyloid peptide oligomer in their brains decreased significantly.
18.07.2011The introduction of the CCL22 protein gene into the beta cells of the pancreas of mice with a model of diabetes stops the autoimmune reaction and protects the subjects from type 1 diabetes.
11.07.2011A method capable of neutralizing mutations that lead to the appearance of premature stop codons on the matrix RNA gives hope for recovery to every third of patients with hereditary diseases.
30.06.2011Gamma-aminobutyric acid, synthesized by beta cells of the pancreas, not only prevents the development of type 1 diabetes, but also cures this disease in mice. The next step is clinical research, on volunteers.
30.06.2011Scientists have cured hemophilia (so far – in mice) using the genome editing method – a new step in the development of gene therapy.
29.06.2011The cell drug laViv, developed by the American company Fibrocell Science, became the first anti-wrinkle drug approved by the FDA. The drug is made for a specific customer from his own fibroblasts.
24.06.2011The introduction of the extracellular matrix of the porcine bladder or small intestine into the injury zone contributes to the unprecedented restoration of lost muscle tissue.
23.06.2011As a next step, Dr. Schubert and his group plan to test the effectiveness of antimicrobial peptides on animal models of infectious diseases.
14.06.2011You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.